# Radical Resection Vs. Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLC

> **NCT01753414** · PHASE2 · UNKNOWN · sponsor: **Radiation Therapy Oncology Group** · enrollment: 44 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **RADIATION:** Stereotactic Body Radiation Therapy (SBRT)
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT01753414
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2023-04-03
- **Final completion:** 2026-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2025-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01753414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01753414, "Radical Resection Vs. Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLC". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT01753414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*